The FDA's approval of a new generic version of mifepristone has sparked backlash from anti-abortion groups and GOP politicians. Critics say it's a political move during a heated debate over abortion rights.
A groundbreaking injectable HIV prevention drug will be available for just $40 a year in over 100 countries by 2027, thanks to agreements between Unitaid, the Gates Foundation, and Indian pharmaceutical companies.
